New E4H report describing recommendations for activities to increase the attractiveness of Europe for performing clinical trials
Enhancing Europe’s attractiveness as a destination for clinical trials is vital to sustaining its global competitiveness in medical research, improving patient access to innovative therapies, strengthening global healthcare systems and fostering economic growth.
ECRIN is delighted to share a new deliverable, within the context of the E4H project. The new report describes recommendations for activities to increase the attractiveness of Europe for performing clinical trials as a part of the ERA4Health project.
Based on a previous analysis of bottlenecks for implementation of multinational clinical trials in Europe, this report describes how different initiatives, including ERA4Health and ACT-EU, are currently working on providing solutions and what is missing.
Implementation of proposed recommendations would contribute to creating a more integrated, agile, and patient-centered clinical research ecosystem across Europe.
